Table 2 Interval of RGC according to variables
Variables | Interval (month) | Effect size (Cohen’ d) | 95% CI | p value |
|---|---|---|---|---|
Age (years) | ||||
< 65(n = 25) | 92.4 ± 67.7 (14–256) | - | - | 0.208 |
≥ 65(n = 23) | 119.8 ± 80.7 (14–350) | 0.369 | − 0.202, 0.94 | |
Sex | ||||
Male (n = 42) | 109.2 ± 76.1 (14–350) | - | - | 0.372 |
Female (n = 6) | 79.8 ± 63.7 (15–179) | − 0.393 | − 1.252, 0.465 | |
Previous cancer stage | ||||
Stage I (n = 30) | 103.0 ± 80.1 (14–350) | - | 0.810 | |
Stage II (n = 11) | 101.7 ± 58.1 (15–225) | − 0.016 | − 0.707, 0.673 | |
Stage III (n = 7) | 122.8 ± 81.6 (28–256) | 0.247 | − 0.577, 1.071 | |
Previous PRM (cm) | ||||
< 3 (n = 9) | 66.0 ± 77.3 | - | - | 0.077 |
≥ 3 (n = 39) | 114.7 ± 72.0 | 0.667 | − 0.068, 1.404 | |
Previous LI | 0.857 | |||
Positive (n = 17) | 102.9 ± 69.9 | - | - | |
Negative (n = 31) | 107.1 ± 78.3 | 0.054 | − 0.536, 0.646 | |
Previous VI | 0.546 | |||
Positive (n = 3) | 80.0 ± 60.25 | - | - | |
Negative (n = 45) | 107.3 ± 75.8 | 0.362 | − 0.808, 1.533 | |
Reconstruction method | ||||
Billroth I (n = 13) | 67 ± 34.5.5 (14–143) | - | - | 0.003 |
Billroth II (n = 35) | 119.9 ± 80.7 (14–350) | 1.017 | 0.349, 1.686 | |
Recurrence site | ||||
Non-anastomosis (n = 21) | 70.8 ± 53.6 (14–256) | - | - | 0.002 |
Anastomosis (n = 27) | 132.6 ± 78.3 (14–350) | 0.953 | 0.352, 1.554 | |
Differentiation | ||||
Differentiated (n = 21) | 125.6 ± 87.1 (14–350) | - | - | 0.102 |
Undifferentiated (n = 27) | 90 ± 60.6 (14–221) | − 0.485 | − 1.063, 0.09 | |
Lauren classification | ||||
Intestinal (n = 17) | 138.5 ± 88.5 (14–350) | - | - | 0.044 |
Diffuse (n = 18) | 76.2 ± 65.0 (14–206) | − 0.805 | − 1.495, − 0.116 | |
Mixed (n = 13) | 103.0 ± 50.9 (27–190) | − 0.474 | − 1.207, 0.257 | |
RGC stage | ||||
Stage I (n = 24) | 109.7 ± 84.2 (14–350) | - | - | 0.145 |
Stage II (n = 12) | 72.0 ± 47.3 (15–190) | − 0.605 | − 1.312, 0.101 | |
Stage III (n = 12) | 130.9 ± 69.2 (28–256) | 0.266 | − 0.429, 0.961 |